Mesenchymal stem cells derived exosomes: an advanced regenerative medicine strategies for treatment of perianal fistula in inflammatory bowel disease?
Journal of Gastroenterology and Hepatology · 2024
DOI: 10.1111/jgh.16404 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of Gastroenterology and Hepatology, 2024. Verfasst von F Cheng. Beteiligte Einrichtung: Division of Gastroenterology, Zigong First People's Hospital, Zigong, China. Hauptthemen laut MEDLINE: Exosomes, Mesenchymal Stem Cells, Inflammatory Bowel Diseases, Fistula. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
it aimed to evaluate the ef fi cacy and safety of mesenchymal stem cells-derived (MSC-derived) exosomes therapy for complex perianal fi stulas (PFs) in non-Crohn ’ s. The authors identi fi ed the application of MSC-derived exosomes as a novel intervention for PFs in patients without in fl ammatory bowel disease (IBD) demonstrated signi fi cant potential. The intervention has the potential to be an effective alternative to current PFs treatments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Gastroenterology, Zigong First People's Hospital, Zigong, China.
ORCID-Profile: F Cheng
Zitieren
APA
Cheng, F. (2024). Mesenchymal stem cells derived exosomes: an advanced regenerative medicine strategies for treatment of perianal fistula in inflammatory bowel disease?. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.16404
Vancouver
Cheng F. Mesenchymal stem cells derived exosomes: an advanced regenerative medicine strategies for treatment of perianal fistula in inflammatory bowel disease?. Journal of Gastroenterology and Hepatology. 2024. doi:10.1111/jgh.16404
BibTeX
@article{Cheng2024,
author = {Cheng, F},
title = {Mesenchymal stem cells derived exosomes: an advanced regenerative medicine strategies for treatment of perianal fistula in inflammatory bowel disease?},
journal = {Journal of Gastroenterology and Hepatology},
year = {2024},
doi = {10.1111/jgh.16404}
}
EUVIMED